Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03318666 · ClinicalTrials.gov registry record · NA
Supporting Our Valued Adolescents Pilot Randomized Controlled Trial
A NA study of Depression and Anxiety, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
- 1
- Study location
NCT03318666: Completed NA study of Depression and Anxiety, sponsored by University of Pittsburgh.
NCT03318666 is a NA study of Depression and Anxiety that has completed, run by University of Pittsburgh. The registered enrollment target is 38 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03318666, a NA study of Depression and Anxiety, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this pilot study is to provide preliminary findings testing the Supporting Our Valued Adolescents (SOVA) intervention, two social media sites (one for adolescents, one for parents) aiming to address negative health beliefs, knowledge about depression or anxiety, parent-adolescent communication, in a moderated online peer community, with the goal of increasing adolescent use of mental health services.
Primary Outcome
proportion of dyads accessing 6-week to those who access baseline surveys
Conditions Studied
Interventions
- OTHER Enhanced Usual Care
- BEHAVIORAL Supporting Our Valued Adolescents (SOVA)
Study Locations (1)
Pennsylvania
- Center for Adolescent and Young Adult Health - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2018-04-17 |
| Est. Completion | 2020-04-06 |
| Phase | NA |
What the finished NCT03318666 record still lists
NCT03318666 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Enhanced Usual Care is the first listed.
NCT03318666 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03318666 about?
NCT03318666 is a clinical study titled "Supporting Our Valued Adolescents Pilot Randomized Controlled Trial". The purpose of this pilot study is to provide preliminary findings testing the Supporting Our Valued Adolescents (SOVA) intervention, two social media sites (one for adolescents, one for parents) aiming to address negative health beliefs, knowledge about depression or anxiety, parent-adolescent comm...
What is the current status of trial NCT03318666?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2018-04-17. Estimated completion is 2020-04-06.
What conditions does trial NCT03318666 study?
This clinical trial studies the following conditions: Depression, Anxiety.
What interventions are being tested in trial NCT03318666?
The interventions under investigation include: Enhanced Usual Care (OTHER), Supporting Our Valued Adolescents (SOVA) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03318666?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03318666 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03318666's enrollment target sits among peer trials
38 531st of 679 higher than 146 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy